Literature DB >> 18459897

Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop.

Michael A Williams1, James P McAllister, Marion L Walker, Dory A Kranz, Marvin Bergsneider, Marc R Del Bigio, Laurel Fleming, David M Frim, Katrina Gwinn, John R W Kestle, Mark G Luciano, Joseph R Madsen, Mary Lou Oster-Granite, Giovanna Spinella.   

Abstract

OBJECT: Treatment for hydrocephalus has not advanced appreciably since the advent of cerebrospinal fluid (CSF) shunts more than 50 years ago. Many questions remain that clinical and basic research could address, which in turn could improve therapeutic options. To clarify the main issues facing hydrocephalus research and to identify critical advances necessary to improve outcomes for patients with hydrocephalus, the National Institutes of Health (NIH) sponsored a workshop titled "Hydrocephalus: Myths, New Facts, and Clear Directions." The purpose of this paper is to report on the recommendations that resulted from that workshop.
METHODS: The workshop convened from September 29 to October 1, 2005, in Bethesda, Maryland. Among the 150 attendees was an international group of participants, including experts in pediatric and adult hydrocephalus as well as scientists working in related fields, neurosurgeons, laboratory-based neuroscientists, neurologists, patient advocates, individuals with hydrocephalus, parents, and NIH program and intramural staff. Plenary and breakout sessions covered injury and recovery mechanisms, modeling, biomechanics, diagnosis, current treatment and outcomes, complications, quality of life, future treatments, medical devices, development of research networks and information sharing, and education and career development.
RESULTS: The conclusions were as follows: 1) current methods of diagnosis, treatment, and outcomes monitoring need improvement; 2) frequent complications, poor rate of shunt survival, and poor quality of life for patients lead to unsatisfactory outcomes; 3) investigators and caregivers need additional methods to monitor neurocognitive function and control of CSF variables such as pressure, flow, or pulsatility; 4) research warrants novel interdisciplinary approaches; 5) understanding of the pathophysiological and recovery mechanisms of neuronal function in hydrocephalus is poor, warranting further investigation; and 6) both basic and clinical aspects warrant expanded and innovative training programs.
CONCLUSIONS: The research priorities of this workshop provide critical guidance for future research in hydrocephalus, which should result in advances in knowledge, and ultimately in the treatment for this important disorder and improved outcomes in patients of all ages.

Entities:  

Mesh:

Year:  2007        PMID: 18459897     DOI: 10.3171/PED-07/11/345

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  26 in total

Review 1.  Who will care for me next? Transitioning to adulthood with hydrocephalus.

Authors:  Tamara D Simon; Sara Lamb; Nancy A Murphy; Bonnie Hom; Marion L Walker; Edward B Clark
Journal:  Pediatrics       Date:  2009-10-19       Impact factor: 7.124

2.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

Review 3.  Shunt overdrainage syndrome: review of the literature.

Authors:  Bienvenido Ros; Sara Iglesias; Álvaro Martín; Antonio Carrasco; Guillermo Ibáñez; Miguel A Arráez
Journal:  Neurosurg Rev       Date:  2017-03-29       Impact factor: 3.042

4.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

5.  Reinfection following initial cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Matthew Hall; J Michael Dean; John R W Kestle; Jay Riva-Cambrin
Journal:  J Neurosurg Pediatr       Date:  2010-09       Impact factor: 2.375

6.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

7.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

8.  Neural stem cell therapy of foetal onset hydrocephalus using the HTx rat as experimental model.

Authors:  Roberto Henzi; Karin Vío; Clara Jara; Conrad E Johanson; James P McAllister; Esteban M Rodríguez; Montserrat Guerra
Journal:  Cell Tissue Res       Date:  2020-02-17       Impact factor: 5.249

9.  Differential vulnerability of white matter structures to experimental infantile hydrocephalus detected by diffusion tensor imaging.

Authors:  Ramin Eskandari; Osama Abdullah; Cameron Mason; Kelley E Lloyd; Amanda N Oeschle; James P McAllister
Journal:  Childs Nerv Syst       Date:  2014-07-29       Impact factor: 1.475

Review 10.  A Review of Clinical Outcomes for Gait and Other Variables in the Surgical Treatment of Idiopathic Normal Pressure Hydrocephalus.

Authors:  Richard Shaw; Neil Mahant; Erica Jacobson; Brian Owler
Journal:  Mov Disord Clin Pract       Date:  2016-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.